Cairo – Mubasher: Memphis Pharmaceutical and Chemical turned to profitability in the first seven months of FY15/16.
The company saw net profits of EGP 585,000 in the first seven months of FY15/16, against losses of EGP 9.2 million for the same period a year earlier.
Earlier, the drug firm posted net profits of EGP 420,000 for the first half of FY15/16, against losses of EGP 9.9 million for the similar period of the previous year.
